Adamas Pharma (ADMS) Reports Q1 Loss of $1.06/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Adamas Pharma (ADMS) Reports Q1 Loss of $1.06/Share

Mizuho Securities Downgrades Adamas Pharmaceuticals (ADMS) to Underperform

March 5, 2019 6:24 AM EST

Mizuho Securities analyst Irina Koffler downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) from Neutral to Underperform with a price target of $5.00 (from $11.00) after guidance was withdrawn.

we believe the launch is likely going even worse than we thoughtWe now model $58.5M in 2019... More